[Recording available] Immuno-oncology research workshop | Day 1

2023-01-31 | 07:30 AM - 10:30 AM (GMT+01:00) Paris


< Day 1 >

Program of the first day

15.30-15.45 Opening

Moderator: Prof. Didier MARTY-DESSUS, Counsellor for Science and Technology,
Embassy of France
  • Mr Tetsuya ITANI, Director - Office of Global Health Cooperation, International
  • Affairs Division, Ministry of Health, Labour and Welfare
  • Dr. Hitoshi NAKAGAMA, President, National Cancer Center of Japan
  • Prof. Norbert IFRAH, President of the French National Cancer Institute
  • Mr Thierry BRETON, General Director of the French National Cancer Institute

15.45-16.20 Session 1

Franco-Japanese Immuno-Oncology webinar series - wrap up and key messages
Chair: Dr Hiroyuki Mano
  • Dr Hiroyoshi Nishikawa, National Cancer Center

16.20-17.05 Session 2

Genomics and metabolomics of the immune microenvironment
Chair: Dr Hiroyuki MANO
  • Overcoming Cancer Immunotherapy Resistance Caused by Tumor-Derived Metabolites, Dr. Shogo KUMAGAI, National Cancer Center
  • Raison d'être of gut microbiome: Immune regulation and beyond, Prof. Koji HASE, Keio University

17.05-17.20 Break

17.20-18.30 Session 3

Heterogeneity, clonal evolution and immune response
Chair: Dr. Hiroyoshi NISHIKAWA
  • Immune cells with somatic mutations function as a niche for cancer cells - clonal hematopoiesis and cancers, Prof. Mamiko SAKATA, University of Tsukuba
  • Clonal evolution in normal lung tissue leading to lung cancer development, Dr. Kenichi YOSHIDA, National Cancer Center
  • Tertiary lymphoid structures in cancer patients: a biomarker and a target for next generation of immunotherapy, Dr. Marie-Caroline DIEU-NOSJEAN, Centre d’Immunologie et des Maladies Infectieuses (CIMI)- Paris (online)

18.30-19.00 Session 4

Development of immune-based targeted therapies
Chair: Dr. Hiroyoshi NISHIKAWA
  • Restriction of PD-1 function for optimal T cell responses, Prof. Taku OKAZAKI, University of Tokyo